Search Results - Kai Pollard
- Showing 1 - 4 results of 4
-
1
-
2
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma by Patience Odeniyide, Marielle E. Yohe, Kai Pollard, Angelina V. Vaseva, Ana Calizo, Lindy Zhang, Fausto J. Rodríguez, John Gross, Amy N. Allen, Xiaolin Wan, Romel Somwar, Karisa C. Schreck, Linda Kessler, Jiawan Wang, Christine A. Pratilas
Published 2022Artigo -
3
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors by Jiawan Wang, Ana Calizo, Lindy Zhang, James C. Pino, Yang Lyu, Kai Pollard, Xiaochun Zhang, Alex T. Larsson, Eric Conniff, Nicolás J. Llosa, David K. Wood, David A. Largaespada, Susan E. Moody, Sara J.C. Gosline, Angela C. Hirbe, Christine A. Pratilas
Published 2023Artigo -
4
Chromosome 8 gain is associated with high-grade transformation in MPNST by Carina Dehner, Chang In Moon, Xiyuan Zhang, Zhaohe Zhou, Chris Miller, Hua Xu, Xiaodan Wan, Kuangying Yang, R. Jay Mashl, Sara J.C. Gosline, Yuxi Wang, Xiaochun Zhang, Abigail Godec, Paul A. Jones, Sonika Dahiya, Himanshi Bhatia, Tina Primeau, Shunqiang Li, Kai Pollard, Fausto J. Rodríguez, Li Ding, Christine A. Pratilas, Jack F. Shern, Angela C. Hirbe
Published 2021Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Medicine
Biochemistry
Cell biology
Gene
Genetics
In vivo
Apoptosis
Bioinformatics
Biotechnology
Chemistry
Chromosome
Effector
Enzyme
Exome
Exome sequencing
Farnesyltransferase
HRAS
In vitro
Internal medicine
KRAS
Kinome
MAPK/ERK pathway
MEK inhibitor
Malignant peripheral nerve sheath tumor
Mutation
Neuroblastoma RAS viral oncogene homolog
Neurofibromatoses
Neurofibromatosis